134 results
8-K
EX-99.1
INVA
Innoviva Inc
27 Apr 22
Innoviva Reports First Quarter 2022 Financial Results
6:43pm
over year, displaying strong positive momentum in a volatile, pandemic-influenced environment."
“RELVAR®/BREO® ELLIPTA® global net sales decreased … advantage of the current environment and drive long-term value creation.”
Recent Highlights
GSK Net Sales:
First quarter 2022 net sales of RELVAR®/BREO®
8-K
EX-99.1
INVA
Innoviva Inc
9 Feb 22
Innoviva Reports Fourth Quarter 2021 Financial Results
4:55pm
in a volatile environment.”
“RELVAR®/BREO® ELLIPTA® global net sales increased 3% compared to the fourth quarter of 2020 supported by increased patient … business development, and we are excited about many opportunities we see in the current environment to advance our strategy. We are well positioned
8-K/A
EX-10.2
INVA
Innoviva Inc
6 Mar 14
Entry into a Material Definitive Agreement
12:00am
but the Parties acknowledge that the same depth of information with regard to the market environment and dynamics may not be available in the less developed … / Changes
(iv) Environment update: Changes and new insights
A. Regulatory
B. Market access
C. Customers
D. Competitors
(v) Market research / Update
8-K
EX-99.2
INVA
Innoviva Inc
20 Jan 10
Regulation FD Disclosure
12:00am
, sort of regardless of the environment.
Q&A from Audience: Can you also address the competitive landscape, like with Novartis and any insights on how … company that I pay a lot of attention to with regard to, you know, competitive environment.
Rick Winningham of Theravance: And I think when once again
8-K
EX-99.1
INVA
Innoviva Inc
20 May 21
Innoviva Announces Strategic Repurchase of GSK’s Equity Stake
5:12pm
in the face of a challenging environment, and look forward to continued work with GSK to address significant unmet medical needs for patients suffering from
8-K
EX-99.1
7j0 b9t71
9 Jan 14
ANORO™ ELLIPTA™ approved for COPD treatment in Canada
12:00am
8-K
EX-99.1
c2pyxfe92 nsdhgt
27 Oct 21
Innoviva Reports Third Quarter 2021 Financial Results
4:18pm
8-K
EX-99.1
0lqwjc
28 Oct 20
Innoviva Reports Third Quarter 2020 Financial Results
4:37pm
8-K
EX-99.1
d422ac hb8je1d721
15 Sep 17
Trelegy Ellipta once-daily single inhaler triple therapy receives positive opinion from the CHMP in Europe for appropriate patients with COPD
12:00am
SC TO-C
EX-99.1
gxv9n lbcz4usta
23 May 22
Information about tender offer
8:54pm
8-K
EX-99
toagfcjmm 3j5g
10 Sep 13
Regulation FD Disclosure
12:00am
8-K
EX-99.1
1jgyhv857s5f9yoo9
3 Feb 21
Innoviva Reports Fourth Quarter 2020 Financial Results
5:14pm
8-K
EX-99.1
dm9gt8
27 Jul 22
Innoviva Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress
4:16pm
8-K
EX-99.1
4poqrwacvx
29 Jul 20
Innoviva Reports Second Quarter 2020 Financial Results
5:21pm
8-K
EX-99.1
qr741kz7gv 48
28 Jul 21
Innoviva Reports Second Quarter 2021 Financial Results
4:26pm
8-K
EX-99
gh9p98dnv3ung4
7 Jul 14
Other Events
12:00am
8-K
EX-99.1
vi4lataadoo pogurbjz
29 Jul 20
Innoviva Reports Second Quarter 2020 Financial Results
5:18pm
8-K/A
EX-10.3
hav o4qto
6 Mar 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99
30zb9z
28 Apr 14
Financial Statements and Exhibits
12:00am
SC TO-C
EX-99.2
j4x1xy2s d3
23 May 22
Information about tender offer
8:54pm